Lupin informs about press release

18 Jan 2020 Evaluate

Lupin has informed about press release titled ‘US FDA completes inspection of Lupin’s Vizag API facility’. Pharma major Lupin has announced the completion of an inspection carried out by the United States Food and Drug Administration (US FDA) at its Vizag API manufacturing facility. The inspection was carried out between January 13, 2020 and January 17, 2020. The inspection for the API facility at Vizag closed with five 483 observations.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×